To the Editor:We paid attention to the recent article by Xiao et al.[1].They reviewed a new strategy for expanding the allograft pool,which involves using otherwise-wasted resected liver lobes from patients with large...To the Editor:We paid attention to the recent article by Xiao et al.[1].They reviewed a new strategy for expanding the allograft pool,which involves using otherwise-wasted resected liver lobes from patients with large,symptomatic benign liver tumors as liver transplant donors.Liver transplantation is the ultimate curative treatment for patients with acute or chronic end-stage liver diseases,or malignant liver tumors,but it is restricted due to the limited availability of donor organs.展开更多
文摘To the Editor:We paid attention to the recent article by Xiao et al.[1].They reviewed a new strategy for expanding the allograft pool,which involves using otherwise-wasted resected liver lobes from patients with large,symptomatic benign liver tumors as liver transplant donors.Liver transplantation is the ultimate curative treatment for patients with acute or chronic end-stage liver diseases,or malignant liver tumors,but it is restricted due to the limited availability of donor organs.
